Publication | Open Access
Proton therapy for low‐grade gliomas: Results from a prospective trial
148
Citations
16
References
2015
Year
Patients with low-grade glioma tolerate proton therapy well, and a subset develops neuroendocrine deficiencies. There is no evidence for overall decline in cognitive function or QOL.
| Year | Citations | |
|---|---|---|
Page 1
Page 1